메뉴 건너뛰기
Annals of Oncology
Volumn 22, Issue 2, 2011, Pages 479-480
Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer
Author keywords

[No Author keywords available]
Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; BEVACIZUMAB; CAPECITABINE; CISPLATIN; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; KI 67 ANTIGEN; LETROZOLE; METHOTREXATE; PACLITAXEL; PROGESTERONE RECEPTOR; TRASTUZUMAB;
EID: 79251575906     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq688     Document Type: Letter
Times cited : (5)
References (7)
  • 1
    • 0027283498 scopus 로고
    • Stability of HER2/neu expression over time and at multiple metastatic sites
    • Niehans GA, Singleton TP, Dykoski D, Kiang DT. Stability of HER2/neu expression over time and at multiple metastatic sites. J Natl Cancer Inst 1993; 85: 1230-1235.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 1230-1235
    • Niehans, G.A.1    Singleton, T.P.2    Dykoski, D.3    Kiang, D.T.4
  • 2
    • 0035990831 scopus 로고    scopus 로고
    • Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
    • Gancberg D, Di Leo A, Cardoso F et al. Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann Oncol 2002; 13: 1036-1043.
    • (2002) Ann Oncol , vol.13 , pp. 1036-1043
    • Gancberg, D.1    Di Leo, A.2    Cardoso, F.3
  • 3
    • 58149237085 scopus 로고    scopus 로고
    • HER-2/neu expression in primary and metastatic breast cancer
    • Lower EE, Glass E, Blau R, Harman S. HER-2/neu expression in primary and metastatic breast cancer. Breast Cancer Res Treat 2009; 113: 301-306.
    • (2009) Breast Cancer Res Treat , vol.113 , pp. 301-306
    • Lower, E.E.1    Glass, E.2    Blau, R.3    Harman, S.4
  • 4
    • 50649094876 scopus 로고    scopus 로고
    • HER2 gene amplification (HER2) and hormone receptor expression (ER/PR) in early (EBC) and metastatic breast cancer (MBC) in the same patients
    • (Abstr 1023)
    • Wilking U, Skoog L, Elmberger G et al. HER2 gene amplification (HER2) and hormone receptor expression (ER/PR) in early (EBC) and metastatic breast cancer (MBC) in the same patients. J Clin Oncol 2007; 25 (18 Suppl): (Abstr 1023).
    • (2007) J Clin Oncol , vol.25 , Issue.18 SUPPL
    • Wilking, U.1    Skoog, L.2    Elmberger, G.3
  • 5
    • 50649119930 scopus 로고    scopus 로고
    • Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management
    • Guarneri V, Giovannelli S, Ficarra G et al. Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management. Oncologist 2008; 13: 838-844.
    • (2008) Oncologist , vol.13 , pp. 838-844
    • Guarneri, V.1    Giovannelli, S.2    Ficarra, G.3
  • 6
    • 0142151070 scopus 로고    scopus 로고
    • The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer
    • Lee SH, Chung MA, Quddus MR et al. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer. Am J Surg 2003; 186(4): 348-350.
    • (2003) Am J Surg , vol.186 , Issue.4 , pp. 348-350
    • Lee, S.H.1    Chung, M.A.2    Quddus, M.R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.